Testing effectiveness (Phase 2)Study completedNCT02176031
What this trial is testing
Phase II Trial of Natalizumab + Prednisone for Initial Therapy of Acute GI GVHD
Who this might be right for
Graft Versus Host Disease
Dana-Farber Cancer Institute 21